---
title: 'Diagnosis, treatment, and surveillance of Diamond-Blackfan anaemia syndrome:
  international consensus statement'
date: '2024-05-02'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38697731/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240503181600&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Diamond-Blackfan anaemia (DBA), first described over 80 years ago, is
  a congenital disorder of erythropoiesis with a predilection for birth defects and
  cancer. Despite scientific advances, this chronic, debilitating, and life-limiting
  disorder continues to cause a substantial physical, psychological, and financial
  toll on patients and their families. The highly complex medical needs of affected
  patients require specialised expertise and multidisciplinary care. However, gaps
  remain in ...
disable_comments: true
---
Diamond-Blackfan anaemia (DBA), first described over 80 years ago, is a congenital disorder of erythropoiesis with a predilection for birth defects and cancer. Despite scientific advances, this chronic, debilitating, and life-limiting disorder continues to cause a substantial physical, psychological, and financial toll on patients and their families. The highly complex medical needs of affected patients require specialised expertise and multidisciplinary care. However, gaps remain in ...